Rockwell Medical, Inc.
RMTI
$0.9559
$0.02612.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.82% | 21.38% | 22.37% | 24.58% | 13.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.82% | 21.38% | 22.37% | 24.58% | 13.45% |
| Cost of Revenue | 3.63% | 12.14% | 13.12% | 18.38% | 12.42% |
| Gross Profit | 90.45% | 100.87% | 104.59% | 87.97% | 22.89% |
| SG&A Expenses | 13.43% | 18.15% | 5.20% | -4.07% | -13.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.26% | 11.74% | 10.59% | 13.58% | 5.97% |
| Operating Income | 108.71% | 109.12% | 107.17% | 69.25% | 43.30% |
| Income Before Tax | 96.86% | 94.31% | 86.69% | 58.89% | 36.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 96.86% | 94.31% | 86.69% | 58.89% | 36.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 96.86% | 94.31% | 86.69% | 58.89% | 36.54% |
| EBIT | 108.71% | 109.12% | 107.17% | 69.25% | 43.30% |
| EBITDA | 157.96% | 153.35% | 139.30% | 90.62% | 56.87% |
| EPS Basic | 94.60% | 92.38% | 89.78% | 81.29% | 70.77% |
| Normalized Basic EPS | 98.10% | 95.66% | 91.41% | 80.63% | 70.28% |
| EPS Diluted | 92.68% | 90.81% | 88.72% | 80.94% | 70.51% |
| Normalized Diluted EPS | 97.61% | 95.25% | 91.10% | 80.58% | 70.28% |
| Average Basic Shares Outstanding | 26.09% | 45.24% | 75.36% | 125.47% | 135.51% |
| Average Diluted Shares Outstanding | 28.49% | 48.10% | 78.95% | 128.55% | 135.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |